Sleep Disorders in Transient Ischemic Attack and Stroke: SOMN'AIC Study (SOMN'AIC)

November 15, 2021 updated by: Hospices Civils de Lyon

Comparison of the Prevalence of Sleep Disorders in Transient Ischemic Attack and Stroke

Sleep disorders in the setting of stroke are numerous, including sleep-related breathing disorders, insomnia, excessive daytime sleepiness and restless legs syndrome. Consequences of theses sleep disturbances include impaired functional outcome and quality of life, anxious and depressive troubles and increased cardio-vascular morbi-mortality. Mechanisms underlying sleep disorders in the setting of stroke are complex and still partly elucidated. They probably involve the consequences of the ischemic lesion and of the handicap, but also of associated vascular risk factors and more generally pre-existent medical history, or they could represent themselves a risk factor for stroke. Transient ischemic attack (TIA) is a particular condition in which risk factors and background of patients are similar to that observed in stroke, without any cerebral lesion and no persistent neurological deficit. The main objective of the SOMN'AIC study is to compare the prevalence of sleep disorders in stroke and in transient ischemic attack (TIA). The study hypothesis is that the prevalence of sleep disorders may be higher in stroke than in TIA patients, reflecting the consequences of the lesion and the associated handicap.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bron, France, 69477
        • Recruiting
        • Service de Neurologie Vasculaire Groupement Hospitalier Est
        • Sub-Investigator:
          • Laurent Derex, PH
        • Sub-Investigator:
          • Elodie Ong, PH
      • Lyon, France, 69004
        • Active, not recruiting
        • Sleep Medicine Center, Croix-Rousse Hospital, Hospices Civils de Lyon
      • Saint-Genis-Laval, France, 69230
        • Recruiting
        • Service de MPR- Hôpital Henry Gabrielle - Groupement Sud
        • Sub-Investigator:
          • Jacques Luauté, PU-PH
        • Sub-Investigator:
          • Sophie Jacquin Courtois, PU-PH
        • Sub-Investigator:
          • Maxime Cheminon, PH
        • Sub-Investigator:
          • Laure HUCHON, PH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Stroke and transient ischemic attack patients

Description

Inclusion Criteria:

  • Stroke group: patients with a diagnosis of stoke and seen at the routine post-stroke 3 month' rehabilitation examination
  • TIA group: diagnosis of a TIA by a stroke specialist at the "SOS TIA" examination
  • > 18 years

Exclusion Criteria:

  • Refusal to participate
  • Severe cognitive impairment leading to inability to fulfil questionnaires
  • For the TIA group: presence of an ischemic lesion on CT scan or MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stroke patients
Patients seen by a rehabilitation physician at a routine 3 months' post-stroke examination
  • Questionnaires about excessive daytime sleepiness (Epworth scale), insomnia (Severity of Insomnia Scale), Restless Legs Syndrome, Chronotype (Horne and Ostberg questionnaire), Sleep apnoea syndrome (Berlin questionnaire)
  • Clinical evaluation
  • Routine neuropsychological evaluation (for stroke patients)
  • Routine Polysomnography for patients with high suspicion of sleep apnoea syndrome (SOS score (Epworth + Berlin) > 10)
TIA patients
Patients seen by a stroke specialist at the "SOS TIA" examination
  • Questionnaires about excessive daytime sleepiness (Epworth scale), insomnia (Severity of Insomnia Scale), Restless Legs Syndrome, Chronotype (Horne and Ostberg questionnaire), Sleep apnoea syndrome (Berlin questionnaire)
  • Clinical evaluation
  • Routine neuropsychological evaluation (for stroke patients)
  • Routine Polysomnography for patients with high suspicion of sleep apnoea syndrome (SOS score (Epworth + Berlin) > 10)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of stroke and transient ischemic attack population regarding the prevalence of the presence of at least one sleep disorder
Time Frame: Maximum 9 months
Presence of at least one of the following sleep disorders assessed by clinical evaluation, questionnaires +/- polysomnography: insomnia, excessive daytime sleepiness (EDS), restless legs syndrome (RLS) and sleep apnoea syndrome (SAS)
Maximum 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 14, 2017

Primary Completion (Anticipated)

November 14, 2022

Study Completion (Anticipated)

August 14, 2023

Study Registration Dates

First Submitted

September 5, 2017

First Submitted That Met QC Criteria

September 5, 2017

First Posted (Actual)

September 7, 2017

Study Record Updates

Last Update Posted (Actual)

November 16, 2021

Last Update Submitted That Met QC Criteria

November 15, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Questionnaires

3
Subscribe